Bellerophon Therapeutics, Inc.
BLPH
BLPH was delisted on the 13th of October, 2023.
20 hedge funds and large institutions have $58.6M invested in Bellerophon Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
18% more funds holding
Funds holding: 17 → 20 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less capital invested
Capital invested by funds: $68.4M → $58.6M (-$9.77M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$518K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$255K |
| 3 |
Morgan Stanley
New York
|
+$155K |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$51.9K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$23.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIG
Senator Investment Group
New York
|
-$1.18M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$211K |
| 3 |
Millennium Management
New York
|
-$142K |
| 4 |
Goldman Sachs
New York
|
-$41.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.34K |
BLPH Hedge Fund Activity: Q2 2015 in Review
20 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Bellerophon Therapeutics, Inc. (BLPH) for Q2 2015, worth a combined $58.6M — down 14% from $68.4M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BLPH positions and 1 closed out — a net gain of 3 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $518K. The largest seller was Senator Investment Group, cutting an estimated $1.18M.
- 20 institutional investors held Bellerophon Therapeutics, Inc. (BLPH) as of Q2 2015, up from 17 in Q1 2015.
- Funds reported $58.6M of Bellerophon Therapeutics, Inc. stock for Q2 2015, down 14% quarter-over-quarter.
- 4 funds opened new Bellerophon Therapeutics, Inc. positions in Q2 2015 and 1 closed out, a net change of +3 holders.
- The largest Bellerophon Therapeutics, Inc. buyer in Q2 2015 was Vanguard Group, an estimated $518K added.
- The largest Bellerophon Therapeutics, Inc. seller in Q2 2015 was Senator Investment Group, an estimated $1.18M sold.
Based on aggregated 13F filings for Q2 2015.